These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30017593)

  • 21. [Antinuclear, anticentromere and anti-ScL-70 antibodies in rheumatic diseases].
    Ivanova SM; Melkumova KL; Il'in KV; Riazantseva TA; Piven' VA; Speranskiĭ AI
    Lab Delo; 1990; (6):50-3. PubMed ID: 1699041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Moyamoya disease as a rare cause of ischaemic stroke--case report].
    Kułakowska A; Kapica-Topczewska K; Borowik H; Drozdowski W
    Pol Merkur Lekarski; 2009 Oct; 27(160):334-7. PubMed ID: 19928665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A patient with systemic sclerosis, severe cytopenias and the simultaneous presence of anti-centromere and anti-SCL-70-antibodies.
    Hietarinta M; Tertti R; Lassila O
    Clin Exp Rheumatol; 1993; 11(4):457-8. PubMed ID: 8403594
    [No Abstract]   [Full Text] [Related]  

  • 24. Moyamoya syndrome associated with neurofibromatosis Type 1: perioperative and long-term outcome after surgical revascularization.
    Koss M; Scott RM; Irons MB; Smith ER; Ullrich NJ
    J Neurosurg Pediatr; 2013 Apr; 11(4):417-25. PubMed ID: 23373626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous thrombolysis, mechanical embolectomy, and intracranial stenting for hyperacute ischemic stroke in a patient with moyamoya disease.
    Argetsinger DS; Miller JW; Fletcher JJ
    J Clin Neurosci; 2016 Jul; 29():173-5. PubMed ID: 26896911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The PM-Scl (polymyositis-scleroderma) autoantibody and its nucleolar fluorescence pattern].
    Kühn G; Jarzabek-Chorzelska M; Blaszczyk M; Kolacinska-Strasz Z; Chorzelski TP; Jablonska S
    Dermatol Monatsschr; 1989; 175(8):479-83. PubMed ID: 2676628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Moyamoya syndrome causing stroke in young women with type 1 diabetes.
    Hughes JW; Wyckoff JA; Hollander AS; Derdeyn CP; McGill JB
    J Diabetes Complications; 2016; 30(8):1640-1642. PubMed ID: 27592246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Moyamoya syndrome associated with neurofibromatosis type I in a pediatric patient.
    Darrigo Júnior LG; Valera ET; Machado Ade A; Santos AC; Scrideli CA; Tone LG
    Sao Paulo Med J; 2011 Mar; 129(2):110-2. PubMed ID: 21603789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Centromere antibodies and antibodies against Scl 70 nucleoprotein in progressive systemic scleroderma. Diagnostic and prognostic significance].
    Meurer M; Scharf A; Luderschmidt C; Braun-Falco O
    Dtsch Med Wochenschr; 1985 Jan; 110(1):8-14. PubMed ID: 3880700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PM-Scl-75 is the main autoantigen in patients with the polymyositis/scleroderma overlap syndrome.
    Raijmakers R; Renz M; Wiemann C; Egberts WV; Seelig HP; van Venrooij WJ; Pruijn GJ
    Arthritis Rheum; 2004 Feb; 50(2):565-9. PubMed ID: 14872500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cockayne Syndrome Complicated by Moyamoya Vasculopathy and Stroke.
    Stowe RC; Jimenez-Gomez A; Balasa A; Clark GD
    Pediatr Neurol; 2018 Sep; 86():73-74. PubMed ID: 30089552
    [No Abstract]   [Full Text] [Related]  

  • 32. Reversible diffusion weighted imaging hyperintensities during the acute phase of ischemic stroke in pediatric moyamoya disease: a case report.
    Tamura G; Ihara S; Morota N
    Childs Nerv Syst; 2016 Aug; 32(8):1531-5. PubMed ID: 26971501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pial Synangiosis Ameliorates Movement Disorders in the Absence of Prior Stroke in Moyamoya Disease.
    Greene S; Bansal L; Coffman KA; Nardone R; Zuccoli G
    J Child Neurol; 2016 Apr; 31(5):646-51. PubMed ID: 26450280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgical outcomes following encephaloduroarteriosynangiosis in North American adults with moyamoya.
    Agarwalla PK; Stapleton CJ; Phillips MT; Walcott BP; Venteicher AS; Ogilvy CS
    J Neurosurg; 2014 Dec; 121(6):1394-400. PubMed ID: 25280094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stroke after adenotonsillectomy in patients with undiagnosed moyamoya syndrome.
    Ahn AK; Honeybrook A; Jordan LC; Singer RJ; Tylor DA
    JAMA Otolaryngol Head Neck Surg; 2014 Nov; 140(11):1061-4. PubMed ID: 25257069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Moyamoya and Down syndrome. Clinical and radiological features.
    Cramer SC; Robertson RL; Dooling EC; Scott RM
    Stroke; 1996 Nov; 27(11):2131-5. PubMed ID: 8898827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-SSA/Ro52 autoantibodies in scleroderma: results of an observational, cross-sectional study.
    Sánchez-Montalvá A; Fernández-Luque A; Simeón CP; Fonollosa-Plà V; Marín A; Guillén A; Vilardell M
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-177-82. PubMed ID: 25372801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patterns of cerebral ischemia in children with moyamoya.
    Rafay MF; Armstrong D; Dirks P; MacGregor DL; deVeber G
    Pediatr Neurol; 2015 Jan; 52(1):65-72. PubMed ID: 25459363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Moyamoya Vasculopathy in PHACE Syndrome: Six New Cases and Review of the Literature.
    Tortora D; Severino M; Accogli A; Martinetti C; Vercellino N; Capra V; Rossi A; Pavanello M
    World Neurosurg; 2017 Dec; 108():291-302. PubMed ID: 28887276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic sclerosis with sarcoidosis: case report and review of the published work.
    Senda S; Igawa K; Nishioka M; Murota H; Katayama I
    J Dermatol; 2014 May; 41(5):421-3. PubMed ID: 24617417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.